AMG-171

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAMG-171
Drug Alias NameGDF15-Fc fusion protein (Amgen)AMG-171
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGDNF family receptor alpha-like agonistsGrowth/differentiation factor 15 analog
TargetsGDNF family receptor alpha-likeGrowth/differentiation factor 15
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A